Azenta Inc
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, in… Read more
Azenta Inc (AZTA) - Net Assets
Latest net assets as of December 2025: $1.71 Billion USD
Based on the latest financial reports, Azenta Inc (AZTA) has net assets worth $1.71 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.07 Billion) and total liabilities ($359.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.71 Billion |
| % of Total Assets | 82.67% |
| Annual Growth Rate | 21.16% |
| 5-Year Change | 30.45% |
| 10-Year Change | 212.25% |
| Growth Volatility | 150.97 |
Azenta Inc - Net Assets Trend (1994–2025)
This chart illustrates how Azenta Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Azenta Inc (1994–2025)
The table below shows the annual net assets of Azenta Inc from 1994 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.73 Billion | -2.27% |
| 2024-09-30 | $1.77 Billion | -30.20% |
| 2023-09-30 | $2.53 Billion | -24.64% |
| 2022-09-30 | $3.36 Billion | +153.78% |
| 2021-09-30 | $1.33 Billion | +9.21% |
| 2020-09-30 | $1.21 Billion | +6.52% |
| 2019-09-30 | $1.14 Billion | +58.71% |
| 2018-09-30 | $717.83 Million | +18.13% |
| 2017-09-30 | $607.64 Million | +9.74% |
| 2016-09-30 | $553.69 Million | -12.40% |
| 2015-09-30 | $632.04 Million | -1.69% |
| 2014-09-30 | $642.89 Million | +1.62% |
| 2013-09-30 | $632.66 Million | -2.56% |
| 2012-09-30 | $649.30 Million | +25.20% |
| 2011-09-30 | $518.60 Million | +33.20% |
| 2010-09-30 | $389.35 Million | +21.82% |
| 2009-09-30 | $319.62 Million | -41.07% |
| 2008-09-30 | $542.40 Million | -36.95% |
| 2007-09-30 | $860.24 Million | +7.59% |
| 2006-09-30 | $799.53 Million | +157.17% |
| 2005-09-30 | $310.89 Million | -0.93% |
| 2004-09-30 | $313.81 Million | +92.53% |
| 2003-09-30 | $162.99 Million | -47.20% |
| 2002-09-30 | $308.73 Million | -27.35% |
| 2001-09-30 | $424.93 Million | +2.38% |
| 2000-09-30 | $415.04 Million | +189.03% |
| 1999-09-30 | $143.60 Million | +17.90% |
| 1998-09-30 | $121.80 Million | -9.24% |
| 1997-09-30 | $134.20 Million | +164.69% |
| 1996-09-30 | $50.70 Million | +24.26% |
| 1995-09-30 | $40.80 Million | +806.67% |
| 1994-09-30 | $4.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Azenta Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 50612.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.42 Billion | 82.22% |
| Common Stock | $594.00K | 0.03% |
| Other Comprehensive Income | $-22.21 Million | -1.29% |
| Other Components | $328.65 Million | 19.03% |
| Total Equity | $1.73 Billion | 100.00% |
Azenta Inc Competitors by Market Cap
The table below lists competitors of Azenta Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cresud SACIF y A
NASDAQ:CRESY
|
$895.70 Million |
|
Penguin Solutions, Inc.
NASDAQ:PENG
|
$896.05 Million |
|
Adani Wilmar Limited
NSE:AWL
|
$896.44 Million |
|
Kinpo Electronics Inc
TW:2312
|
$896.54 Million |
|
Gelex Group JSC
VN:GEX
|
$895.44 Million |
|
Chengdu Haoneng Tech Co Ltd
SHG:603809
|
$894.77 Million |
|
China Suntien Green Energy Corporation Limited
PINK:CSGEF
|
$894.23 Million |
|
Gray Television Inc
NYSE:GTN-A
|
$894.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Azenta Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,768,967,000 to 1,726,986,000, a change of -41,981,000 (-2.4%).
- Net loss of 55,763,000 reduced equity.
- New share issuances of 2,770,000 increased equity.
- Other comprehensive income decreased equity by 8,749,000.
- Other factors increased equity by 19,761,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-55.76 Million | -3.23% |
| Share Issuances | $2.77 Million | +0.16% |
| Other Comprehensive Income | $-8.75 Million | -0.51% |
| Other Changes | $19.76 Million | +1.14% |
| Total Change | $- | -2.37% |
Book Value vs Market Value Analysis
This analysis compares Azenta Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.59x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 22.95x to 0.59x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-09-30 | $0.96 | $22.03 | x |
| 1995-09-30 | $6.39 | $22.03 | x |
| 1996-09-30 | $5.88 | $22.03 | x |
| 1997-09-30 | $17.03 | $22.03 | x |
| 1998-09-30 | $11.78 | $22.03 | x |
| 1999-09-30 | $12.70 | $22.03 | x |
| 2000-09-30 | $24.07 | $22.03 | x |
| 2001-09-30 | $23.55 | $22.03 | x |
| 2002-09-30 | $11.94 | $22.03 | x |
| 2003-09-30 | $4.41 | $22.03 | x |
| 2004-09-30 | $7.20 | $22.03 | x |
| 2005-09-30 | $6.90 | $22.03 | x |
| 2006-09-30 | $11.02 | $22.03 | x |
| 2007-09-30 | $11.61 | $22.03 | x |
| 2008-09-30 | $8.40 | $22.03 | x |
| 2009-09-30 | $5.07 | $22.03 | x |
| 2010-09-30 | $6.06 | $22.03 | x |
| 2011-09-30 | $7.97 | $22.03 | x |
| 2012-09-30 | $9.87 | $22.03 | x |
| 2013-09-30 | $9.59 | $22.03 | x |
| 2014-09-30 | $9.50 | $22.03 | x |
| 2015-09-30 | $9.22 | $22.03 | x |
| 2016-09-30 | $8.08 | $22.03 | x |
| 2017-09-30 | $8.62 | $22.03 | x |
| 2018-09-30 | $10.12 | $22.03 | x |
| 2019-09-30 | $15.74 | $22.03 | x |
| 2020-09-30 | $16.43 | $22.03 | x |
| 2021-09-30 | $17.80 | $22.03 | x |
| 2022-09-30 | $44.91 | $22.03 | x |
| 2023-09-30 | $38.25 | $22.03 | x |
| 2024-09-30 | $33.27 | $22.03 | x |
| 2025-09-30 | $37.63 | $22.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Azenta Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.39%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.19x
- Recent ROE (-3.23%) is above the historical average (-10.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 33.33% | 6.25% | 1.88x | 2.84x | $1.05 Million |
| 1995 | 11.27% | 10.07% | 0.90x | 1.25x | $520.00K |
| 1996 | 16.77% | 9.40% | 1.40x | 1.28x | $3.43 Million |
| 1997 | 0.60% | 0.93% | 0.58x | 1.12x | $-12.62 Million |
| 1998 | -15.11% | -18.42% | 0.71x | 1.16x | $-30.58 Million |
| 1999 | -5.56% | -7.60% | 0.59x | 1.25x | $-22.11 Million |
| 2000 | 3.08% | 3.97% | 0.63x | 1.24x | $-28.63 Million |
| 2001 | -6.99% | -7.77% | 0.54x | 1.66x | $-72.08 Million |
| 2002 | -233.57% | -236.63% | 0.46x | 2.13x | $-750.78 Million |
| 2003 | -114.46% | -54.06% | 0.70x | 3.04x | $-201.99 Million |
| 2004 | 8.69% | 5.08% | 0.80x | 2.14x | $-4.09 Million |
| 2005 | -3.25% | -2.17% | 0.74x | 2.01x | $-41.04 Million |
| 2006 | 3.24% | 4.27% | 0.61x | 1.24x | $-53.98 Million |
| 2007 | 7.86% | 9.09% | 0.73x | 1.18x | $-18.40 Million |
| 2008 | -43.66% | -44.95% | 0.79x | 1.22x | $-290.82 Million |
| 2009 | -71.40% | -104.18% | 0.53x | 1.30x | $-259.77 Million |
| 2010 | 15.17% | 9.95% | 1.14x | 1.33x | $20.10 Million |
| 2011 | 24.78% | 18.65% | 1.08x | 1.23x | $76.55 Million |
| 2012 | 21.09% | 26.33% | 0.70x | 1.14x | $71.92 Million |
| 2013 | -0.35% | -0.52% | 0.57x | 1.17x | $-65.41 Million |
| 2014 | 0.69% | 0.92% | 0.62x | 1.21x | $-59.83 Million |
| 2015 | 2.25% | 2.57% | 0.73x | 1.20x | $-48.98 Million |
| 2016 | -12.55% | -12.40% | 0.82x | 1.24x | $-124.84 Million |
| 2017 | 10.30% | 11.87% | 0.69x | 1.26x | $1.85 Million |
| 2018 | 16.24% | 18.46% | 0.58x | 1.53x | $44.79 Million |
| 2019 | 2.53% | 3.69% | 0.51x | 1.33x | $-85.11 Million |
| 2020 | 5.34% | 16.69% | 0.25x | 1.28x | $-56.51 Million |
| 2021 | 8.36% | 21.56% | 0.28x | 1.37x | $-21.79 Million |
| 2022 | -12.75% | -77.22% | 0.15x | 1.10x | $-765.30 Million |
| 2023 | -0.56% | -2.14% | 0.23x | 1.14x | $-267.71 Million |
| 2024 | -9.32% | -28.76% | 0.27x | 1.19x | $-341.79 Million |
| 2025 | -3.23% | -9.39% | 0.29x | 1.19x | $-228.46 Million |
Industry Comparison
This section compares Azenta Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Azenta Inc (AZTA) | $1.71 Billion | 33.33% | 0.21x | $895.59 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |